It has been reported that STAT3 signaling regulates the IL-12/IL-23 balance, which directs the transcriptional activation of the IL-23/p19 gene and inhibits IL-12/p35 gene expression in tumor-associated DCs [16]. Here, STAT3 is linked to neoplasm.